Molecular Targets in Alzheimer’s Disease

被引:0
|
作者
Geir Bjørklund
Jan Aaseth
Maryam Dadar
Salvatore Chirumbolo
机构
[1] Council for Nutritional and Environmental Medicine,Faculty of Health and Social Science
[2] Inland Norway University of Applied Sciences,Department of Research
[3] Innlandet Hospital Trust,Agricultural Research, Education and Extension Organization (AREEO)
[4] Razi Vaccine and Serum Research Institute,Department of Neurosciences, Biomedicine and Movement Sciences
[5] University of Verona,undefined
来源
Molecular Neurobiology | 2019年 / 56卷
关键词
Alzheimer’s disease; Amyloid beta; Tau protein; Oxidative stress;
D O I
暂无
中图分类号
学科分类号
摘要
Alzheimer’s disease (AD) is known as a devastating neurodegenerative disorder in aged subjects, which is related to multiple heterogeneous genetic factors. The two basic pathological aspects of AD are related to amyloid beta (Aβ) peptides and tau proteins. Some researchers have demonstrated plaques and tangles as apparently primary lesions. Also, experimental data propose that these two lesions are intimately related. In the present review, we highlight some molecular mechanisms linking tau and Aβ toxicities involving oxidative stress, aging, Aβ turnover, the contribution of thiol groups, and the role mitochondrial activities in the AD pathogenesis. Understanding the interplay of these mechanisms as parts of common pathophysiological pathways could reveal molecular targets to control or even treat AD.
引用
收藏
页码:7032 / 7044
页数:12
相关论文
共 50 条
  • [1] Molecular Targets in Alzheimer's Disease
    Bjorklund, Geir
    Aaseth, Jan
    Dadar, Maryam
    Chirumbolo, Salvatore
    [J]. MOLECULAR NEUROBIOLOGY, 2019, 56 (10) : 7032 - 7044
  • [2] Molecular and Therapeutic Targets of Genistein in Alzheimer’s Disease
    Kasi Pandima Devi
    Balakrishnan Shanmuganathan
    Azadeh Manayi
    Seyed Fazel Nabavi
    Seyed Mohammad Nabavi
    [J]. Molecular Neurobiology, 2017, 54 : 7028 - 7041
  • [3] Alzheimer's disease: Molecular concepts and therapeutic targets
    Fassbender K.
    Masters C.
    Beyreuther K.
    [J]. Naturwissenschaften, 2001, 88 (6) : 261 - 267
  • [4] Molecular Targets of Tannic Acid in Alzheimer's Disease
    Braidy, Nady
    Jugder, Bat-Erdene
    Poljak, Anne
    Jayasena, Tharusha
    Nabavi, Seyed Mohammad
    Sachdev, Perminder
    Grant, Ross
    [J]. CURRENT ALZHEIMER RESEARCH, 2017, 14 (08) : 861 - 869
  • [5] Alzheimer's disease: molecular concepts and therapeutic targets
    Fassbender, K
    Masters, C
    Beyreuther, K
    [J]. NATURWISSENSCHAFTEN, 2001, 88 (06) : 261 - 267
  • [6] Molecular and Therapeutic Targets of Genistein in Alzheimer's Disease
    Devi, Kasi Pandima
    Shanmuganathan, Balakrishnan
    Manayi, Azadeh
    Nabavi, Seyed Fazel
    Nabavi, Seyed Mohammad
    [J]. MOLECULAR NEUROBIOLOGY, 2017, 54 (09) : 7028 - 7041
  • [7] Molecular drug targets and therapies for Alzheimer's disease
    Singh, Dev Bukhsh
    Gupta, Manish Kumar
    Kesharwani, Rajesh Kumar
    Sagar, Mamta
    Dwivedi, Seema
    Misra, Krishna
    [J]. TRANSLATIONAL NEUROSCIENCE, 2014, 5 (03) : 203 - 217
  • [8] Emerging molecular targets - A key to Alzheimer's disease?
    Gurwitz, D
    [J]. DRUG DISCOVERY TODAY, 1998, 3 (03) : 144 - 144
  • [9] Emerging Therapeutic Targets in Molecular Neuropharmacology for Alzheimer's Disease
    Bano, Sarika
    Raza, Muhammad Asim
    Ghosh, Shampa
    Pandit, Nayaab S.
    Srivastava, Saumya
    Azam, Mohammad
    Dey, Sanjay Kumar
    Han, Sung Soo
    Sinha, Jitendra Kumar
    Ruwali, Munindra
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (11): : 5769 - 5784
  • [10] Molecular network of microRNA targets in Alzheimer's disease brains
    Satoh, Jun-ichi
    [J]. EXPERIMENTAL NEUROLOGY, 2012, 235 (02) : 436 - 446